PTC Therapeutics Gears Up for Sephience Launch Following Positive CHMP Opinion for PKU Treatment PTC Therapeutics has received a favorable opinion from the CHMP for Sephience to treat PKU, signaling major advancements in patient care and access across Europe.

PTC Therapeutics Gears Up for Sephience Launch Following Positive CHMP Opinion for PKU Treatment #United_States #PTC_Therapeutics #Warren #Sephience #PKU_Treatment